|
1
|
Gupta S, Dominguez M and Golestaneh L:
Diabetic kidney disease: An update. Med Clin North Am. 107:689–705.
2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Miller RG and Orchard TJ: Understanding
metabolic memory: A tale of two studies. Diabetes. 69:291–299.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhou Z, Sun B, Huang S, Zhu C and Bian M:
Glycemic variability: Adverse clinical outcomes and how to improve
it? Cardiovasc Diabetol. 19(102)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
DeVries JH: Glucose variability: Where it
is important and how to measure it. Diabetes. 62:1405–1408.
2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Papachristoforou E, Lambadiari V, Maratou
E and Makrilakis K: Association of glycemic indices (hyperglycemia,
glucose variability, and hypoglycemia) with oxidative stress and
diabetic complications. J Diabetes Res.
2020(7489795)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wentholt IME, Kulik W, Michels RPJ,
Hoekstra JBL and DeVries JH: Glucose fluctuations and activation of
oxidative stress in patients with type 1 diabetes. Diabetologia.
51:183–190. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Colomo N, López-Siguero JP, Leiva I,
Fuentes N, Rubio-Martín E, Omiste A, Guerrero M, Tapia MJ,
Martín-Tejedor B, Ruiz de Adana MS and Olveira G: Relationship
between glucose control, glycemic variability, and oxidative stress
in children with type 1 diabetes. Endocrinol Diabetes Nutr (Engl
Ed). 66:540–549. 2019.PubMed/NCBI View Article : Google Scholar : (English,
Spanish).
|
|
8
|
Dimova R, Chakarova N, Grozeva G, Kirilov
G and Tankova T: The relationship between glucose variability and
insulin sensitivity and oxidative stress in subjects with
prediabetes. Diabetes Res Clin Pract. 158(107911)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wadén J, Forsblom C, Thorn LM, Gordin D,
Saraheimo M and Groop PH: A1C variability predicts incident
cardiovascular events, microalbuminuria, and overt diabetic
nephropathy in patients with type 1 diabetes. Diabetes.
58:2649–2655. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Battelino T, Danne T, Bergenstal RM, Amiel
SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL,
et al: Clinical targets for continuous glucose monitoring data
interpretation: Recommendations from the international consensus on
time in range. Diabetes Care. 42:1593–1603. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Purandare VB, Bale C, Kakrani A and
Unnikrishnan AG: Understanding glycemic variability. J Diabetology.
12:275–284. 2021.
|
|
12
|
Lachin JM, Bebu I, Bergenstal RM,
Pop-Busui R, Service FJ, Zinman B and Nathan DM: Association of
glycemic variability in type 1 diabetes with progression of
microvascular outcomes in the diabetes control and complications
trial. Diabetes Care. 40:777–783. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ling J, Ng JKC, Chan JCN and Chow E: Use
of continuous glucose monitoring in the assessment and management
of patients with diabetes and chronic kidney disease. Front
Endocrinol (Lausanne). 13(869899)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bomholt T, Rix M, Almdal T, Knop FK,
Rosthøj S, Jørgensen MB, Feldt-Rasmussen B and Hornum M: Glucose
variability in maintenance hemodialysis patients with type 2
diabetes: Comparison of dialysis and nondialysis days. Hemodial
Int. 27:126–133. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bushljetik IR, Trajceska L, Pusevski V and
Spasovski G: Glucose levels during dialysis with glucose-free
versus glucose-rich dialysate fluid. Prilozi. 40:41–46.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
El Malahi A, Van Elsen M, Charleer S,
Dirinck E, Ledeganck K, Keymeulen B, Crenier L, Radermecker R, Taes
Y, Vercammen C, et al: Relationship between time in range, glycemic
variability, HbA1c, and complications in adults with type 1
diabetes mellitus. J Clin Endocrinol Metab. 107:e570–e581.
2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kovatchev B: Glycemic variability: Risk
factors, assessment, and control. J Diabetes Sci Technol.
13:627–635. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Galindo RJ, Beck RW, Scioscia MF,
Umpierrez GE and Tuttle KR: Glycemic monitoring and management in
advanced chronic kidney disease. Endocr Rev. 41:756–774.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ahola AJ, Radzeviciene L, Zaharenko L,
Bulum T, Skrebinska S, Prakapiene E, Blaslov K, Roso V, Rovite V,
Pirags V, et al: Association between symptoms of depression,
diabetes complications and vascular risk factors in four European
cohorts of individuals with type 1 diabetes-InterDiane Consortium.
Diabetes Res Clin Pract. 170(108495)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zamora-Ros R, Biessy C, Rothwell JA, Monge
A, Lajous M, Scalbert A, López-Ridaura R and Romieu I: Dietary
polyphenol intake and their major food sources in the Mexican
Teachers' Cohort. Br J Nutr. 120:353–360. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sokolovska J, Dekante A, Baumane L,
Pahirko L, Valeinis J, Dislere K, Rovite V, Pirags V and Sjakste N:
Nitric oxide metabolism is impaired by type 1 diabetes and diabetic
nephropathy. Biomed Rep. 12:251–258. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
American Diabetes Association Professional
Practice Committee. 11. Chronic Kidney Disease and Risk Management:
Standards of Care in Diabetes-2024. Diabetes Care. 47 (Suppl
1):S219–S230. 2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Colombo M, Valo E, McGurnaghan SJ,
Sandholm N, Blackbourn LAK, Dalton RN, Dunger D, Groop PH, McKeigue
PM, Forsblom C, et al: Biomarker panels associated with progression
of renal disease in type 1 diabetes. Diabetologia. 62:1616–1627.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Levey AS, Stevens LA, Schmid CH, Zhang YL,
Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene
T, et al: A new equation to estimate glomerular filtration rate.
Ann Intern Med. 150(604)2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wadén J, Tikkanen H, Forsblom C, Fagerudd
J, Pettersson-Fernholm K, Lakka T, Riska M and Groop PH: FinnDiane
Study Group. Leisure time physical activity is associated with poor
glycemic control in type 1 diabetic women. Diabetes Care.
28:777–782. 2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
R Core Team: A language and environment
for statistical computing, 2023.
|
|
27
|
Wickham H: ggplot2: Create Elegant Data
Visualisations Using the Grammar of Graphics, 2024.
|
|
28
|
Griggs S and Morris NS: Fatigue among
adults with type 1 diabetes mellitus and implications for
self-management: An integrative review. Diabetes Educ. 44:325–339.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Fedulovs A, Tzivian L, Zalizko P, Ivanova
S, Bumane R, Janeviča J, Krūzmane L, Krustins E and Sokolovska J:
Progression of diabetic kidney disease and gastrointestinal
symptoms in patients with type I diabetes. Biomedicines.
11(2679)2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Williams S, Raheim SA, Khan MI, Rubab U,
Kanagala P, Zhao SS, Marshall A, Brown E and Alam U: Cardiac
autonomic neuropathy in type 1 and 2 diabetes: Epidemiology,
pathophysiology, and management. Clin Ther. 44:1394–1416.
2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yun JS, Park YM, Han K, Kim HW, Cha SA,
Ahn YB and Ko SH: Severe hypoglycemia and the risk of end stage
renal disease in type 2 diabetes. Sci Rep. 11(4305)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Sagmeister MS, Harper L and Hardy RS:
Cortisol excess in chronic kidney disease-A review of changes and
impact on mortality. Front Endocrinol (Lausanne).
13(1075809)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hamilton A, Zhang Q, Salehi A, Willems M,
Knudsen JG, Ringgaard AK, Chapman CE, Gonzalez-Alvarez A, Surdo NC,
Zaccolo M, et al: Adrenaline stimulates glucagon secretion by
Tpc2-dependent Ca2+ mobilization from acidic stores in pancreatic
α-cells. Diabetes. 67:1128–1139. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ceriello A, Esposito K, Piconi L, Ihnat
MA, Thorpe JE, Testa R, Boemi M and Giugliano D: Oscillating
glucose is more deleterious to endothelial function and oxidative
stress than mean glucose in normal and type 2 diabetic patients.
Diabetes. 57:1349–1354. 2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Costantino S, Paneni F, Battista R,
Castello L, Capretti G, Chiandotto S, Tanese L, Russo G, Pitocco D,
Lanza GA, et al: Impact of glycemic variability on chromatin
remodeling, oxidative stress, and endothelial dysfunction in
patients with type 2 diabetes and with target HbA1c levels.
Diabetes. 66:2472–2482. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yapanis M, James S, Craig ME, O'Neal D and
Ekinci EI: Complications of diabetes and metrics of glycemic
management derived from continuous glucose monitoring. J Clin
Endocrinol Metab. 107:e2221–e2236. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Šoupal J, Škrha J, Fajmon M, Horová E,
Mráz M, Škrha J and Prázný M: Glycemic variability is higher in
type 1 diabetes patients with microvascular complications
irrespective of glycemic control. Diabetes Technol Ther.
16:198–203. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Gheith O, Farouk N, Nampoory N, Halim MA
and Al-Otaibi T: Diabetic kidney disease: World wide difference of
prevalence and risk factors. J Nephropharmacol. 5:49–56.
2016.PubMed/NCBI
|
|
39
|
Ohta M, Babazono T, Uchigata Y and Iwamoto
Y: Comparison of the prevalence of chronic kidney disease in
Japanese patients with Type 1 and Type 2 diabetes. Diabetic
Medicine. 27:1017–1023. 2010.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Marshall SM: Natural history and clinical
characteristics of CKD in Type 1 and Type 2 diabetes mellitus. Adv
Chronic Kidney Dis. 21:267–272. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Bergenstal RM: Glycemic variability and
diabetes complications: Does it matter? Simply put, there are
better glycemic markers! Diabetes Care. 38:1615–1621.
2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Habte-Asres HH, Wheeler DC and Forbes A:
The association between glycaemic variability and progression of
chronic kidney disease: A Systematic Review. Compr Clin Med.
4(102)2022.
|
|
43
|
Jansson Sigfrids F, Lithovius R, Groop P
and Thorn LM: Lessons learned from the FinnDiane Study:
Epidemiology and metabolic risk factors for diabetic kidney disease
in type 1 diabetes. Diabet Med. (e15431)2024.PubMed/NCBI View Article : Google Scholar : doi:
10.1111/dme.15431 (Epub ahead of print).
|
|
44
|
Targher G, Mantovani A, Pichiri I,
Mingolla L, Cavalieri V, Mantovani W, Pancheri S, Trombetta M,
Zoppini G, Chonchol M, et al: Nonalcoholic fatty liver disease is
independently associated with an increased incidence of chronic
kidney disease in patients with type 1 diabetes. Diabetes Care.
37:1729–1736. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Clinck I, Mertens J, Wouters K, Dirinck E
and De Block C: Insulin resistance and CGM-Derived parameters in
people with type 1 diabetes: Are they associated? J Clin Endocrinol
Metab. 109:e2131–e2140. 2024.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Grube D, Wei G, Boucher R, Abraham N, Zhou
N, Gonce V, Carle J, Simmons DL and Beddhu S: Insulin use in
chronic kidney disease and the risk of hypoglycemic events. BMC
Nephrol. 23(73)2022.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Amiel SA: The consequences of
hypoglycaemia. Diabetologia. 64:963–970. 2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Bumbu A, Moutairou A, Matar O, Fumeron F,
Velho G, Riveline JP, Gautier JF, Marre M, Roussel R and Potier L:
Non-severe hypoglycaemia is associated with weight gain in patients
with type 1 diabetes: Results from the Diabetes Control and
Complication Trial. Diabetes Obes Metab. 20:1289–1292.
2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Jakubowska Z and Malyszko J: Continuous
glucose monitoring in people with diabetes and end-stage kidney
disease-review of association studies and Evidence-Based
discussion. J Nephrol. 37:267–279. 2023.PubMed/NCBI View Article : Google Scholar
|
|
50
|
van Duinkerken E, Snoek FJ and de Wit M:
The cognitive and psychological effects of living with type 1
diabetes: A narrative review. Diabet Med. 37:555–563.
2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Szadkowska A, Czyżewska K, Pietrzak I,
Mianowska B, Jarosz-Chobot P and Myśliwiec M: Hypoglycaemia
unawareness in patients with type 1 diabetes. Pediatr Endocrinol
Diabetes Metab. 24:126–134. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Vloemans AF, van Beers CAJ, de Wit M,
Cleijne W, Rondags SM, Geelhoed-Duijvestijn PH, Kramer MHH, Serné
EH and Snoek FJ: Keeping safe. Continuous glucose monitoring (CGM)
in persons with Type 1 diabetes and impaired awareness of
hypoglycaemia: A qualitative study. Diabet Med. 34:1470–1476.
2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Friedman JG, Cardona Matos Z, Szmuilowicz
ED and Aleppo G: Use of continuous glucose monitors to manage type
1 diabetes mellitus: Progress, challenges, and recommendations.
Pharmgenomics Pers Med. 16:263–276. 2023.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Rickels MR, Peleckis AJ, Dalton-Bakes C,
Naji JR, Ran NA, Nguyen HL, O'Brien S, Chen S, Lee I and Schutta
MH: Continuous glucose monitoring for hypoglycemia avoidance and
glucose counterregulation in long-standing type 1 diabetes. J Clin
Endocrinol Metab. 103:105–114. 2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Choudhary P, Ramasamy S, Green L, Gallen
G, Pender S, Brackenridge A, Amiel SA and Pickup JC: Real-time
continuous glucose monitoring significantly reduces severe
hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes.
Diabetes Care. 36:4160–4162. 2013.PubMed/NCBI View Article : Google Scholar
|
